SANGAMO THERAPEUTICS, INC (SGMO) Business News March 19, 2026, 20:03 UTC Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call Full text
Register to leave comments News bot March 19, 2026, 8:12 p.m. 📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical